Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis

Gil Y. Melmed, Phillip R. Fleshner, Ovunc Bardakcioglu, Andrew Ippoliti, Eric A. Vasiliauskas, Konstantinos A. Papadakis, Marla Dubinsky, Carol Landers, Jerome I. Rotter, Stephan R. Targan

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Abstract

PURPOSE: Approximately 5 to 10 percent of patients undergoing ileal pouch-anal anastomosis with a diagnosis of ulcerative colitis are subsequently diagnosed with Crohn's disease. Preoperative predictors for Crohn's disease post-ileal pouch-anal anastomosis have not been prospectively defined. METHODS: A total of 238 consecutive patients with ulcerative colitis or indeterminate colitis undergoing ileal pouch-anal anastomosis were prospectively enrolled into a longitudinal database. Clinical factors were assessed perioperatively. Serum drawn preoperatively was assayed for anti-Saccharomyces cerevisiae, antiouter membrane porin-C, anti-CBir1, and perinuclear antineutrophil cytoplasmic antibody using enzyme-linked immunosorbent assay. Crohn's disease was defined by small bowel inflammation proximal to the ileal pouch or a perianal fistula identified at least three months after ileostomy closure. Predictors were assessed in a multivariate Cox proportional hazards model to predict the rate of Crohn's disease after ileostomy closure. RESULTS: Sixteen patients (7 percent) were diagnosed with Crohn's disease; median time to Crohn's disease was 19 (range, 1-41) months. Significant factors for postoperative Crohn's disease after ileal pouch-anal anastomosis included family history of Crohn's disease (hazard ratio, 8.4; 95 percent confidence interval, 2.96-24.1; P < 0.0001) and anti-Saccharomyces cerevisiae immunoglobulin-A seropositivity (hazard ratio, 3.14; 95 percent confidence interval, 1.1-9.81; P = 0.04). Crohn's disease developed in only 8 of 198 patients (4 percent) without these predictors vs. 8 of 40 patients (20 percent) in those with at least one of these factors (P = 0.002). The cumulative risk of Crohn's disease among patients with two risk factors (67 percent) was higher than in patients with either risk factor (18 percent) or neither risk factor (4 percent, P < 0.001). CONCLUSIONS: Patients with ulcerative colitis and indeterminate colitis with a family history of Crohn's disease or preoperative anti-Saccharomyces cerevisiae immunoglobulin-A seropositivity are more likely to be diagnosed with Crohn's disease after ileal pouch-anal anastomosis.

Original languageEnglish (US)
Pages (from-to)100-108
Number of pages9
JournalDiseases of the colon and rectum
Volume51
Issue number1
DOIs
StatePublished - Jan 2008

Keywords

  • ASCA
  • Crohn's disease
  • Ileal pouch-anal anastomosis
  • Indeterminate colitis
  • Inflammatory bowel disease
  • OmpC
  • Serology
  • Ulcerative colitis
  • pANCA

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis'. Together they form a unique fingerprint.

Cite this